Similar findings were also observed in gastric cancer that DACH1 was dramatically lower expressed in chemoresistant compared with chemosensitive tumors and could be an independent predictor for chemoresistance.24 Overall, these results suggest that DACH1 could suppress tumor progression and reverse acquired progestin resistance. The gene discussed is DACH1; the disease is gastric cancer.